HIV-1 antibody--debris or virion? by Parren, P, Burton, DR, Sattentau, Q

HIV-1 antibody - Debris or virion? (vol 3, pg 366, 1997) by Parren, P, Burton, DR, Sattentau, Q

Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies? by Scherer, E, Mcmichael, A, Burton, DR

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. by Parren, P, Moore, J, Burton, DR, Sattentau, Q

Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. by Scherer, E, Leaman, D, Zwick, M, Mcmichael, A, Burton, DR

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. by Ugolini, S, Mondor, I, Parren, P, Burton, DR, Tilley, SA, Klasse, P, Sattentau, Q

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". by Parren, P, Gauduin, M, Koup, R, Poignard, P, Sattentau, Q, Fisicaro, P, Burton, DR

The activity of a potent neutralizing human antibody against primary isolates in vivo by Burton, DR, Parren, P, Poignard, P, Mosier, D, Gauduin, M, Koup, R, Sattentau, Q

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. by Parren, P, Mondor, I, Naniche, D, Ditzel, H, Klasse, P, Burton, DR, Sattentau, Q

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design. by Parren, P, Gauduin, M, Koup, R, Poignard, P, Fisicaro, P, Burton, DR, Sattentau, Q

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (vol 57, pg 105, 1997) by Parren, P, Gauduin, M, Koup, R, Poignard, P, Sattentau, Q, Fisicaro, P, Burton, DR

Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. by Dorrell, L, Hessell, A, Wang, M, Whittle, H, Sabally, S, Rowland-Jones, S, Burton, DR, Parren, P

A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity by Doores, K, Fulton, Z, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Burton, DR, Davis, B

Copper refolding of prion protein. by Wong, B, Vénien-Bryan, C, Williamson, R, Burton, DR, Gambetti, P, Sy, MS, Brown, DR, Jones, I

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind... by Astronomo, R, Lee, H, Scanlan, C, Pantophlet, R, Huang, C, Wilson, I, Blixt, O, Dwek, R, Wong, C, Burton, DR

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by s... by Moore, J, Cao, Y, Qing, L, Sattentau, Q, Pyati, J, Koduri, R, Robinson, J, Barbas, C, Burton, DR, Ho, D

A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120 by Rudd, P, Scanlan, C, Pantophlet, R, Wormald, M, Saphire, E, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Burton, DR

A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. by Doores, K, Fulton, Z, Hong, V, Patel, M, Scanlan, C, Wormald, M, Finn, MG, Burton, DR, Wilson, I, Davis, B

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. by Scanlan, C, Pantophlet, R, Wormald, M, Ollmann Saphire, E, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Rudd, P, Burton, DR

The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. by Scanlan, C, Pantophlet, R, Wormald, M, Saphire, E, Calarese, D, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Burton, DR, Rudd, P